|
|
Please log in to edit this profile
|
| Elevator Pitch |
Viamet Pharmaceuticals, Inc recently secured $18 million in a Series B financing to accelerate the development of its novel metalloenzyme inhibitors. |
| Industry Focus |
BioPharma |
| Category |
Companies - Early Stage |
| Location |
2250 Perimeter Park Drive |
|
Suite 320 |
|
Morrisville, North Carolina
27560
|
|
United States |
| |
| Phone |
+919.467.8539 |
| Email |
Please log in |
| Web |
http://www.viamet.com |
|
|
|
Amount: $18,000,000
Closed: July 7, 2009
|
|
|
|
|
|
|
Round: Series B
Amount: Unspecified
Closed: July, 2009
|
|
|
|
|
|
|
Round: Series B
Amount: Unspecified
Closed: July, 2009
|
|
|
|
|
|
|
Round: Series B
Amount: Unspecified
Closed: July, 2009
|
|
|
|
| Be the first to recommend Viamet!
Log in |
Public information, member edits, and the DealHorizon.com team.
|
Office Location
Statistics
Search Site
Edit/Update
Followers
Please log in
Note: Once associated with a listing, Executives are automatically included as followers of that listing. Listing
creators are also automatically added as followers.
|
